Drug Profile

Research programme: in vivo CAR-T cell therapy - China Medical University Hospital/Ever Supreme Bio Technology

Alternative Names: EXO-001 - China Medical University Hospital/Ever Supreme Bio Technology

Latest Information Update: 03 May 2026

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

13 Feb 2026 China Medical University Hospital and Ever Supreme Bio Technology has patent protection for "Production of exosomes and uses thereof" in the US, the European Union, Taiwan, Denmark and Japan and has patent pending applications in China
13 Feb 2026 Preclinical trials in Solid tumours in Taiwan (IV) prior to February 2026
13 Feb 2026 Efficacy and adverse events data from a preclinical study in Solid tumours released by China Medical University Hospital

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com